Valproic acid and Sirolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valproic acid (valproic acid) and Sirolimus (sirolimus). Common drug interactions include melas syndrome among females and adenovirus infection among males.

The phase IV clinical study analyzes what interactions people have when they take Valproic acid and Sirolimus. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Valproic acid?

Valproic acid has active ingredients of valproic acid. It is often used in epilepsy. eHealthMe is studying from 36,193 Valproic acid users. Check the latest studies of Valproic acid.

What is Sirolimus?

Sirolimus has active ingredients of sirolimus. eHealthMe is studying from 11,823 Sirolimus users. Check the latest studies of Sirolimus.



On Jul, 20, 2026

36 people who take Valproic acid and Sirolimus together, and have interactions are studied.

Valproic acid and Sirolimus drug interactions.

What are the common drug interactions of Valproic Acid and Sirolimus, by gender? *:

female:

  1. Melas syndrome (melas (myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) is a progressive neurodegenerative disorder)
  2. Mitochondrial toxicity (a condition in which the mitochondria of a body's cells become damaged or decline significantly in number;)
  3. Abdominal discomfort
  4. Blood cholesterol increased
  5. Blood triglycerides increased
  6. Chest discomfort
  7. Decreased appetite
  8. Disease progression
  9. Status migrainosus (a migraine headache for 72 hours)
  10. Stupor (lack of critical cognitive function and level of consciousness)

male:

  1. Adenovirus infection
  2. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  3. Epistaxis (bleed from the nose)
  4. Lip haemorrhage (bleeding lip)
  5. Respiratory distress (difficulty in breathing)
  6. Stomatitis (inflammation of mucous membrane of mouth)
  7. Hyperammonaemic encephalopathy (excess of ammonia in the blood, disorder or disease of the brain)
  8. Completed suicide (act of taking one's own life)
  9. Drug ineffective
  10. Anticonvulsant drug level increased

What are the common drug interactions of Valproic Acid and Sirolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Adenovirus infection
  2. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  3. Epistaxis (bleed from the nose)
  4. Lip haemorrhage (bleeding lip)
  5. Respiratory distress (difficulty in breathing)
  6. Stomatitis (inflammation of mucous membrane of mouth)

10-19:

  1. Drug ineffective

20-29:

  1. Disease progression

30-39:

  1. Decreased appetite
  2. Status migrainosus (a migraine headache for 72 hours)
  3. Abdominal discomfort
  4. Blood cholesterol increased
  5. Blood triglycerides increased
  6. Chest discomfort

40-49:

  1. Hyperammonaemic encephalopathy (excess of ammonia in the blood, disorder or disease of the brain)

50-59:

  1. Melas syndrome (melas (myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) is a progressive neurodegenerative disorder)
  2. Mitochondrial toxicity (a condition in which the mitochondria of a body's cells become damaged or decline significantly in number;)
  3. Stupor (lack of critical cognitive function and level of consciousness)

60+:

  1. Completed suicide (act of taking one's own life)
  2. Anticonvulsant drug level increased

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 5 people, 13.89%
  2. Immunodeficiency Disorders: 4 people, 11.11%
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 11.11%
  4. Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 3 people, 8.33%
  5. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 8.33%
  6. Stress And Anxiety: 2 people, 5.56%
  7. Status Migrainosus (a migraine headache for 72 hours): 2 people, 5.56%
  8. Partial Seizures (seizures which affect only a part of the brain at onset): 2 people, 5.56%
  9. Hypersensitivity: 2 people, 5.56%
  10. Headache (pain in head): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Valproic acid and Sirolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Valproic acid and Sirolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valproic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sirolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valproic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sirolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on valproic acid and sirolimus (the active ingredients of Valproic acid and Sirolimus, respectively), and Valproic acid and Sirolimus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: